ID4 and prostate carcinoma: Occasionally (seven samples, 17% Table 1), a PCR product was also observed in the un-methylated PCR reaction suggesting that Id4 promoter is partially un-methylated (ranked as 2 for statistical analysis) in prostate cancer specimens.